Screening for endocrine hypertension in China: protocol for a multicentre prospective cohort study.

ABSTRACT:

Introduction

Secondary hypertension accounts for 5%-10% of all hypertensive patients. Among these conditions, endocrine hypertension, such as primary aldosteronism (PA), Cushing's syndrome (CS) and pheochromocytoma and paraganglioma (PPGL), is a common and significantly harmful cause. With advancements in diagnostic techniques, the prevalence of endocrine hypertension is much higher than previously reported, but large-scale epidemiological survey data in this field are still lacking in China.

Methods and analysis

This is a multicentre prospective cohort study to investigate the epidemiological characteristics of endocrine hypertension, such as PA, PPGL and CS, in the Chinese hypertensive population. Standardised clinical assessments, biochemical tests and mass spectrometry-b

SUBMITTER: Zhou Z 

PROVIDER: S-EPMC12406851 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature